The benefits of COVID-19 vaccination outweigh the unknown risks in haematopoietic stem cell transplant and CAR T-cell (TCT) patients. According to the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) consensus position statement, there are currently no studies evaluating COVID-19 vaccines in TCT patients. “Despite the lack of data, there is no immunologic rationale ...
Stem cell transplant and CAR T-cell patients should be first for COVID vaccine
By Mardi Chapman
1 Feb 2021